RNA Exosome Component EXOSC4 Amplified in Multiple Cancer Types Is Required for the Cancer Cell Survival.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Jan 2022
Historique:
received: 30 11 2021
revised: 26 12 2021
accepted: 30 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 27 1 2022
Statut: epublish

Résumé

The RNA exosome is a multi-subunit ribonuclease complex that is evolutionally conserved and the major cellular machinery for the surveillance, processing, degradation, and turnover of diverse RNAs essential for cell viability. Here we performed integrated genomic and clinicopathological analyses of 27 RNA exosome components across 32 tumor types using The Cancer Genome Atlas PanCancer Atlas Studies' datasets. We discovered that the

Identifiants

pubmed: 35008922
pii: ijms23010496
doi: 10.3390/ijms23010496
pmc: PMC8745236
pii:
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
BIK protein, human 0
Mitochondrial Proteins 0
Nuclear Proteins 0
RNA, Messenger 0
RNA-Binding Proteins 0
SESN2 protein, human 0
EXOSC4 protein, human EC 3.1.-
Exosome Multienzyme Ribonuclease Complex EC 3.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 17KK0163, 18H02570, 18KT0016, 20H03655, 20H04838, 21H04792, 21H00243, 21H02758, 21K19402

Références

Clin Cancer Res. 2014 Jun 15;20(12):3118-32
pubmed: 24763612
Genes Dev. 2017 Jan 15;31(2):88-100
pubmed: 28202538
Mod Pathol. 2014 Apr;27(4):580-93
pubmed: 24072181
RNA Biol. 2021 Oct 15;18(sup1):537-547
pubmed: 34470577
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Curr Protoc. 2021 Mar;1(3):e90
pubmed: 33780170
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Mol Cell. 2016 Nov 3;64(3):520-533
pubmed: 27871484
PLoS Genet. 2009 Jul;5(7):e1000555
pubmed: 19593367
Life Sci. 2020 Dec 15;263:118597
pubmed: 33075373
Oxid Med Cell Longev. 2017;2017:3296294
pubmed: 28690762
Nucleic Acids Res. 2021 Sep 20;49(16):9007-9025
pubmed: 34059908
Methods Enzymol. 2008;442:183-99
pubmed: 18662570
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Cell. 2015 May 7;161(4):774-89
pubmed: 25957685
Oncogene. 2002 Apr 11;21(16):2534-44
pubmed: 11971188
BMC Res Notes. 2017 Nov 6;10(1):560
pubmed: 29110683
Oncogene. 2005 Jul 21;24(31):4993-9
pubmed: 15824729
Ann N Y Acad Sci. 2016 May;1371(1):45-54
pubmed: 26599426
J Immunol. 2001 Mar 1;166(5):3130-42
pubmed: 11207265
Mol Carcinog. 2018 Dec;57(12):1780-1791
pubmed: 30155936
J Biol Chem. 2005 Jun 24;280(25):23829-36
pubmed: 15809295
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Br J Haematol. 2015 Apr;169(1):57-70
pubmed: 25521164
Nat Commun. 2015 Apr 09;6:6744
pubmed: 25855536
Orphanet J Rare Dis. 2014 Feb 13;9:23
pubmed: 24524299
PLoS One. 2014 Dec 11;9(12):e114616
pubmed: 25502777
Nat Rev Mol Cell Biol. 2016 Apr;17(4):227-39
pubmed: 26726035
J Mol Biol. 2017 Oct 27;429(21):3230-3241
pubmed: 28069372
Nat Genet. 2012 Apr 29;44(6):704-8
pubmed: 22544365
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
J Clin Oncol. 1990 Nov;8(11):1789-96
pubmed: 2230867
Cancer Res. 2011 Mar 15;71(6):2034-7
pubmed: 21406394
RNA Biol. 2017 Jul 3;14(7):820-826
pubmed: 28421898
Cell Cycle. 2015;14(20):3231-41
pubmed: 26313705
Biol Chem. 2007 Jun;388(6):555-60
pubmed: 17552902
Nature. 2010 Feb 18;463(7283):899-905
pubmed: 20164920
J Med Genet. 2016 Jun;53(6):419-25
pubmed: 26843489
Cell. 2005 Jun 3;121(5):713-24
pubmed: 15935758
J Mol Cell Biol. 2013 Aug;5(4):214-26
pubmed: 23918283
Mol Cell. 2015 Dec 17;60(6):873-85
pubmed: 26687677
Nat Rev Genet. 2018 Aug;19(8):518-529
pubmed: 29748575
Nat Commun. 2014 Jul 03;5:4287
pubmed: 24989451
Mol Cell. 2016 Jul 7;63(1):125-34
pubmed: 27345150
Oncogene. 2008 Dec;27 Suppl 1:S20-9
pubmed: 19641504
Adv Exp Med Biol. 2019;1203:113-132
pubmed: 31811632
Sci Rep. 2020 Jun 9;10(1):9275
pubmed: 32518284
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Trends Biochem Sci. 2013 Oct;38(10):485-93
pubmed: 23910895
Nucleic Acids Res. 2017 Feb 28;45(4):2068-2080
pubmed: 28204585
Methods Mol Biol. 2017;1594:293-308
pubmed: 28456991
Bioinformatics. 2007 Aug 15;23(16):2183-4
pubmed: 17586828
Mol Cell. 2011 Aug 19;43(4):624-37
pubmed: 21855801
Bioinformatics. 2007 Jul 15;23(14):1846-7
pubmed: 17496320
EMBO Rep. 2007 Jul;8(7):651-7
pubmed: 17603538
Mitochondrion. 2017 Nov;37:46-54
pubmed: 28687512
Biochim Biophys Acta. 2013 Jun-Jul;1829(6-7):552-60
pubmed: 23352926
Mol Cell. 2018 Feb 15;69(4):648-663.e7
pubmed: 29398447
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
RNA. 2018 Feb;24(2):127-142
pubmed: 29093021
Life Sci Alliance. 2020 Jun 11;3(8):
pubmed: 32527837
Nat Commun. 2015 Nov 27;6:10025
pubmed: 26612684
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Biochim Biophys Acta. 2016 Dec;1863(12):3125-3147
pubmed: 27713097
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Int J Cancer. 1992 Jul 9;51(5):687-91
pubmed: 1612775
Cell. 2005 Jun 3;121(5):725-37
pubmed: 15935759
Curr Opin Struct Biol. 2014 Feb;24:132-40
pubmed: 24525139
F1000Res. 2020 Feb 26;9:
pubmed: 32148779
Mol Cancer Ther. 2005 Mar;4(3):443-9
pubmed: 15767553

Auteurs

Kenzui Taniue (K)

Isotope Science Center, The University of Tokyo, Tokyo 113-0032, Japan.
Cancer Genomics and Precision Medicine, Department of Medicine, Asahikawa Medical University, Asahikawa 078-8510, Japan.

Tanzina Tanu (T)

Isotope Science Center, The University of Tokyo, Tokyo 113-0032, Japan.

Yuki Shimoura (Y)

Isotope Science Center, The University of Tokyo, Tokyo 113-0032, Japan.

Shuhei Mitsutomi (S)

Isotope Science Center, The University of Tokyo, Tokyo 113-0032, Japan.

Han Han (H)

Isotope Science Center, The University of Tokyo, Tokyo 113-0032, Japan.

Rika Kakisaka (R)

Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo 065-0033, Japan.

Yusuke Ono (Y)

Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo 065-0033, Japan.

Nobue Tamamura (N)

Cancer Genomics and Precision Medicine, Department of Medicine, Asahikawa Medical University, Asahikawa 078-8510, Japan.

Kenji Takahashi (K)

Cancer Genomics and Precision Medicine, Department of Medicine, Asahikawa Medical University, Asahikawa 078-8510, Japan.

Youichiro Wada (Y)

Isotope Science Center, The University of Tokyo, Tokyo 113-0032, Japan.

Yusuke Mizukami (Y)

Cancer Genomics and Precision Medicine, Department of Medicine, Asahikawa Medical University, Asahikawa 078-8510, Japan.

Nobuyoshi Akimitsu (N)

Isotope Science Center, The University of Tokyo, Tokyo 113-0032, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH